CD13 expression in b-cell chronic lymphocytic leukemia is associated with the pattern of bone marrow infiltration

Antonio Pinto, Vittorina Zagonel, Antonino Carbone, Diego Serraino, Giuseppe Marotta, Rachele Volpe, Alfonso Colombatti, Luigi Del Vecchio

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

The ectopic expression of the cell surface peptidase CD13 (aminopeptidase N) and of three other myelomonocytic antigens i.e. CD33, CD14 and CD15 was analyzed by flow cytometry in neoplastic lymphocytes from 81 consecutive patients with B-cell chronic lymphocytic leukemia (B-CLL). CD13 and CD14 antigens were detected on lymphocytes from 30% and 60% of patients respectively whilst a smaller percentage of samples was found positive for CD15 (5%) and CD33 (12%). The presence of CD13 and CD33 antigens on neoplastic B cells showed a statistically significant association with the two most important clinicopathologic prognostic factors in B-CLL: the clinical stage (CD13, p <0.01; CD33, p <0.05-Rai and Binet staging systems) and the pattern of bone marrow infiltration (CD13, p <0.001; CD33, p = 0.02). A multiple logistic regression analysis showed that the increased risk of CD13 positive patients (13.7 fold higher than in CD13 negative cases; p = 0.001) of presenting a diffuse pattern of bone marrow infiltration was independent from all other prognostic factors including sex, lymphocyte counts, age, and clinical stage. Our findings indicate for the first time a statistically significant association of CD13 and CD33 antigens with unfavorable prognostic factors in B-CLL. They suggest that the cross-lineage expression of myeloid-associated surface peptidases (CD13) and/or molecules related to cell adhesion processes (CD33), may influence the behaviour of B-cell chronic lymphoproliferative disorders in analogy to what is reported for acute leukemias and multiple myeloma.

Original languageEnglish
Pages (from-to)209-218
Number of pages10
JournalLeukemia and Lymphoma
Volume6
Issue number3
DOIs
Publication statusPublished - 1992

Fingerprint

CD13 Antigens
Sialic Acid Binding Ig-like Lectin 3
B-Cell Chronic Lymphocytic Leukemia
Bone Marrow
Peptide Hydrolases
B-Lymphocytes
CD15 Antigens
CD14 Antigens
Lymphocytes
Lymphoproliferative Disorders
Lymphocyte Count
Multiple Myeloma
Cell Adhesion
Flow Cytometry
Leukemia
Logistic Models
Regression Analysis

Keywords

  • B-cell chronic lymphocytic leukemia
  • Bone marrow infiltration
  • CD13-Aminopeptidase N
  • Myelomonocytic antigens

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this

CD13 expression in b-cell chronic lymphocytic leukemia is associated with the pattern of bone marrow infiltration. / Pinto, Antonio; Zagonel, Vittorina; Carbone, Antonino; Serraino, Diego; Marotta, Giuseppe; Volpe, Rachele; Colombatti, Alfonso; Vecchio, Luigi Del.

In: Leukemia and Lymphoma, Vol. 6, No. 3, 1992, p. 209-218.

Research output: Contribution to journalArticle

Pinto, Antonio ; Zagonel, Vittorina ; Carbone, Antonino ; Serraino, Diego ; Marotta, Giuseppe ; Volpe, Rachele ; Colombatti, Alfonso ; Vecchio, Luigi Del. / CD13 expression in b-cell chronic lymphocytic leukemia is associated with the pattern of bone marrow infiltration. In: Leukemia and Lymphoma. 1992 ; Vol. 6, No. 3. pp. 209-218.
@article{e4cee64d44dc436ab277cc89cc79039d,
title = "CD13 expression in b-cell chronic lymphocytic leukemia is associated with the pattern of bone marrow infiltration",
abstract = "The ectopic expression of the cell surface peptidase CD13 (aminopeptidase N) and of three other myelomonocytic antigens i.e. CD33, CD14 and CD15 was analyzed by flow cytometry in neoplastic lymphocytes from 81 consecutive patients with B-cell chronic lymphocytic leukemia (B-CLL). CD13 and CD14 antigens were detected on lymphocytes from 30{\%} and 60{\%} of patients respectively whilst a smaller percentage of samples was found positive for CD15 (5{\%}) and CD33 (12{\%}). The presence of CD13 and CD33 antigens on neoplastic B cells showed a statistically significant association with the two most important clinicopathologic prognostic factors in B-CLL: the clinical stage (CD13, p <0.01; CD33, p <0.05-Rai and Binet staging systems) and the pattern of bone marrow infiltration (CD13, p <0.001; CD33, p = 0.02). A multiple logistic regression analysis showed that the increased risk of CD13 positive patients (13.7 fold higher than in CD13 negative cases; p = 0.001) of presenting a diffuse pattern of bone marrow infiltration was independent from all other prognostic factors including sex, lymphocyte counts, age, and clinical stage. Our findings indicate for the first time a statistically significant association of CD13 and CD33 antigens with unfavorable prognostic factors in B-CLL. They suggest that the cross-lineage expression of myeloid-associated surface peptidases (CD13) and/or molecules related to cell adhesion processes (CD33), may influence the behaviour of B-cell chronic lymphoproliferative disorders in analogy to what is reported for acute leukemias and multiple myeloma.",
keywords = "B-cell chronic lymphocytic leukemia, Bone marrow infiltration, CD13-Aminopeptidase N, Myelomonocytic antigens",
author = "Antonio Pinto and Vittorina Zagonel and Antonino Carbone and Diego Serraino and Giuseppe Marotta and Rachele Volpe and Alfonso Colombatti and Vecchio, {Luigi Del}",
year = "1992",
doi = "10.3109/10428199209064897",
language = "English",
volume = "6",
pages = "209--218",
journal = "Leukemia and Lymphoma",
issn = "1042-8194",
publisher = "Taylor and Francis Ltd.",
number = "3",

}

TY - JOUR

T1 - CD13 expression in b-cell chronic lymphocytic leukemia is associated with the pattern of bone marrow infiltration

AU - Pinto, Antonio

AU - Zagonel, Vittorina

AU - Carbone, Antonino

AU - Serraino, Diego

AU - Marotta, Giuseppe

AU - Volpe, Rachele

AU - Colombatti, Alfonso

AU - Vecchio, Luigi Del

PY - 1992

Y1 - 1992

N2 - The ectopic expression of the cell surface peptidase CD13 (aminopeptidase N) and of three other myelomonocytic antigens i.e. CD33, CD14 and CD15 was analyzed by flow cytometry in neoplastic lymphocytes from 81 consecutive patients with B-cell chronic lymphocytic leukemia (B-CLL). CD13 and CD14 antigens were detected on lymphocytes from 30% and 60% of patients respectively whilst a smaller percentage of samples was found positive for CD15 (5%) and CD33 (12%). The presence of CD13 and CD33 antigens on neoplastic B cells showed a statistically significant association with the two most important clinicopathologic prognostic factors in B-CLL: the clinical stage (CD13, p <0.01; CD33, p <0.05-Rai and Binet staging systems) and the pattern of bone marrow infiltration (CD13, p <0.001; CD33, p = 0.02). A multiple logistic regression analysis showed that the increased risk of CD13 positive patients (13.7 fold higher than in CD13 negative cases; p = 0.001) of presenting a diffuse pattern of bone marrow infiltration was independent from all other prognostic factors including sex, lymphocyte counts, age, and clinical stage. Our findings indicate for the first time a statistically significant association of CD13 and CD33 antigens with unfavorable prognostic factors in B-CLL. They suggest that the cross-lineage expression of myeloid-associated surface peptidases (CD13) and/or molecules related to cell adhesion processes (CD33), may influence the behaviour of B-cell chronic lymphoproliferative disorders in analogy to what is reported for acute leukemias and multiple myeloma.

AB - The ectopic expression of the cell surface peptidase CD13 (aminopeptidase N) and of three other myelomonocytic antigens i.e. CD33, CD14 and CD15 was analyzed by flow cytometry in neoplastic lymphocytes from 81 consecutive patients with B-cell chronic lymphocytic leukemia (B-CLL). CD13 and CD14 antigens were detected on lymphocytes from 30% and 60% of patients respectively whilst a smaller percentage of samples was found positive for CD15 (5%) and CD33 (12%). The presence of CD13 and CD33 antigens on neoplastic B cells showed a statistically significant association with the two most important clinicopathologic prognostic factors in B-CLL: the clinical stage (CD13, p <0.01; CD33, p <0.05-Rai and Binet staging systems) and the pattern of bone marrow infiltration (CD13, p <0.001; CD33, p = 0.02). A multiple logistic regression analysis showed that the increased risk of CD13 positive patients (13.7 fold higher than in CD13 negative cases; p = 0.001) of presenting a diffuse pattern of bone marrow infiltration was independent from all other prognostic factors including sex, lymphocyte counts, age, and clinical stage. Our findings indicate for the first time a statistically significant association of CD13 and CD33 antigens with unfavorable prognostic factors in B-CLL. They suggest that the cross-lineage expression of myeloid-associated surface peptidases (CD13) and/or molecules related to cell adhesion processes (CD33), may influence the behaviour of B-cell chronic lymphoproliferative disorders in analogy to what is reported for acute leukemias and multiple myeloma.

KW - B-cell chronic lymphocytic leukemia

KW - Bone marrow infiltration

KW - CD13-Aminopeptidase N

KW - Myelomonocytic antigens

UR - http://www.scopus.com/inward/record.url?scp=0026604912&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026604912&partnerID=8YFLogxK

U2 - 10.3109/10428199209064897

DO - 10.3109/10428199209064897

M3 - Article

VL - 6

SP - 209

EP - 218

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

SN - 1042-8194

IS - 3

ER -